RecruitMe Clinical Trial

Serotonin 1A Receptor Binding in Bipolar Depression Determined by PET Imaging: Prediction of Clinical Response
Brain imaging in bipolar depression to be able to predict who will respond to antidepressant treatment
Sponsor:NIMH
Enrolling:Male and Female Patients
IRB Number:7056
U.S. Government ID:NCT02473250
Contact: Michelle Parris B.S.: 646-774-7627 / parrism@nyspi.columbia.edu
Additional Study Information:

We are trying to understand what causes bipolar disorder and how medications treat bipolar depression. If you participate, you will have two different brain scans (MRI and PET scan). You will also have antidepressant treatment for free. We will then be able to see whether information on the brain scans connects with how people do on the medications. The medications are common, and are not experimental. You will be able to discuss the treatment with Dr. Lan before starting the study to make sure that it is the proper treatment for you. The medications include valproate (Depakote) and either fluoxetine (Prozac) or citalopram (Celexa). The study is funded by the National Institute of Health (NIH) to improve the treatment of bipolar disorder. Please contact us if you are interested in participating.

Do You Qualify?
Do you have a diagnosis of bipolar disorder?YesNo
Are you currently having symptoms of depression?YesNo
Investigator
Martin Lan, MD PHD
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:

Michelle Parris B.S.

parrism@nyspi.columbia.edu

646-774-7627

YesYes2